Authors say increased vigilance is warranted for patients with mucosal damage<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — A history of upper gastrointestinal mucosal damage (MD) is associated with a higher subsequent risk for developing Parkinson disease (PD), according to a study published online Sept. 5 in\u00a0JAMA Network Open<\/em>.<\/p>\n Jocelyn J. Chang, from Tufts University in Boston, and colleagues evaluated the association between upper endoscopy findings of MD (erosions, esophagitis, ulcers, or peptic injury) and a subsequent clinical PD diagnosis. The analysis included 9,350 individuals undergoing upper endoscopy with biopsy from 2000 through 2005, with follow-up through July 31, 2023.<\/p>\n The researchers found that at baseline, patients with MD were more likely to have a history of Helicobacter pylori<\/em> infection, proton pump inhibitor use, chronic nonsteroidal anti-inflammatory drug use, gastroesophageal reflux disease, smoking, constipation, and dysphagia. During a mean 14.9 years of follow-up, patients with MD were more likely to develop PD (incident rate ratio, 4.15; P\u00e2\u0080\u0089<\u00e2\u0080\u00890.001) versus those without MD, even when adjusting for covariates (hazard ratio, 1.76; P\u00e2\u0080\u0089=\u00e2\u0080\u00890.01). PD risk was also higher for those with constipation, dysphagia, older age, and a higher Charlson-Deyo Comorbidity Index.<\/p>\n \u00e2\u0080\u009cIncreased vigilance among patients with MD for future PD risk may be warranted,\u00e2\u0080\u009d the authors wrote.<\/p>\n Abstract\/Full Text\u00a0(subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n